nvo market cap 2009-october 2023

On October 31, 2023, Novo Nordisk A-S (NVO) had a market capitalization of $416.2B, based on 4.48B shares at a price of $92.95.

DATE CLOSE VOLUME OUTSTANDING MARKET CAP
October 2023
$92.95
113,059,800
4,477,400,000
$416,182,389,320.00
September 2023
$87.53
89,019,400
4,489,000,000
$392,934,290,300.00
August 2023
$89.33
92,845,400
4,489,000,000
$401,014,041,400.00
July 2023
$77.16
48,119,400
4,489,000,000
$346,375,729,000.00
June 2023
$77.51
52,715,800
4,502,600,000
$348,999,227,560.00
May 2023
$76.85
62,124,400
4,502,600,000
$346,044,621,440.00
April 2023
$80.03
54,888,200
4,502,600,000
$360,342,627,740.00
March 2023
$76.22
65,591,000
4,513,200,000
$344,006,033,040.00
February 2023
$66.99
50,562,600
4,513,200,000
$302,349,197,040.00
January 2023
$65.94
60,031,400
4,513,200,000
$297,609,885,720.00
December 2022
$64.31
56,107,600
4,522,800,000
$290,850,413,280.00
November 2022
$59.20
58,247,800
4,522,800,000
$267,769,660,320.00
October 2022
$51.72
49,459,400
4,522,800,000
$233,901,124,800.00
September 2022
$47.34
59,285,800
4,537,000,000
$214,780,672,600.00
August 2022
$50.41
111,234,400
4,537,000,000
$228,728,318,000.00
July 2022
$54.85
43,203,000
4,537,000,000
$248,857,172,200.00
June 2022
$52.66
54,052,000
4,552,200,000
$239,729,777,280.00
May 2022
$52.18
69,747,400
4,552,200,000
$237,513,766,320.00
April 2022
$53.88
61,997,400
4,552,200,000
$245,258,879,400.00
March 2022
$52.48
63,493,000
4,566,600,000
$239,667,954,480.00
February 2022
$48.19
50,862,600
4,566,600,000
$220,074,500,520.00
January 2022
$46.75
73,296,600
4,566,600,000
$213,490,376,640.00
December 2021
$52.43
57,472,800
4,585,951,900
$240,435,037,784.34
November 2021
$50.01
37,584,400
4,585,951,900
$229,336,575,591.15
October 2021
$51.55
34,219,600
4,585,951,900
$236,420,495,491.08